| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4142580 | F | Antiproliferative activity against human A549 cells after 48 hrs by SRB assay | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 2. | ALA4142581 | F | Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 3. | ALA4142582 | F | Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 4. | ALA4142583 | F | Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 5. | ALA4142584 | F | Antiproliferative activity against human T47D cells after 48 hrs by SRB assay | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 6. | ALA4142585 | F | Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 7. | ALA4142586 | A | Cytotoxicity against human hTERT-BJ cells assessed as cell growth inhibition after 48 hrs SRB assay | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 8. | ALA4142587 | F | Potency index, ratio of abiraterone GI50 to compound GI50 for human T47D cells | Homo sapiens | 19 | cell-based format | Scientific Literature | ||
| 9. | ALA4142588 | F | Potency index, ratio of galeterone GI50 to compound GI50 for human T47D cells | Homo sapiens | 19 | cell-based format | Scientific Literature | ||
| 10. | ALA4142589 | F | Potency index, ratio of abiraterone GI50 to compound GI50 for human WiDr cells | Homo sapiens | 19 | cell-based format | Scientific Literature | ||
| 11. | ALA4142590 | F | Potency index, ratio of galeterone GI50 to compound GI50 for human WiDr cells | Homo sapiens | 19 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!